BIO-PATH HOLDINGS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bio Path Holdings, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2023.
  • Bio Path Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $200K, unchanged year-over-year.
  • Bio Path Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $900K, unchanged year-over-year.
  • Bio Path Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $700K, a 22.2% decline from 2022.
  • Bio Path Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $900K, a 12.5% increase from 2021.
  • Bio Path Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $800K, a 33.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $900K $200K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $900K $200K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $900K $300K +$100K +50% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $800K $200K -$100K -33.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $900K $200K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $900K $200K +$100K +100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $800K $200K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $800K $300K +$200K +200% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $600K $200K +$100K +100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $500K $100K -$100K -50% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $600K $200K +$100K +100% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $500K $100K -$100K -50% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $600K $100K -$100K -50% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $700K $200K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $700K $100K -$100K -50% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $800K $200K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $800K $200K +$100K +100% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $700K $200K +$100K +100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $600K $200K +$100K +100% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $500K $200K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $500K $100K -$200K -66.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $700K $100K -$100K -50% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $800K $100K -$200K -66.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-19
Q3 2017 $1M $200K $0 0% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1M $300K +$100K +50% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $900K $200K +$100K +100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $800K $300K +$200K +200% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $600K $200K +$100K +100% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $500K $200K +$100K +100% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $400K $100K $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $400K $100K +$27.1K +37.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $373K $100K -$18K -15.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $391K $100K -$22.8K -18.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $414K $100K +$13.7K +15.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $400K $72.9K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $118K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $123K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $86.3K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.